Contemplate the data and tweets to guess whether the closing price of $bmy will surge or decline at 2017-09-07. Please declare either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-08-23,-0.4,0.5,-0.8,0.3,0.3,-1.4,-1.2,-1.6,-2.2,-2.5,-3.0
2017-08-24,-0.3,0.3,-0.6,0.5,0.5,-1.4,-1.5,-1.8,-2.4,-2.8,-3.3
2017-08-25,-0.1,0.5,-0.3,0.3,0.3,-1.1,-1.5,-1.9,-2.5,-3.0,-3.4
2017-08-28,0.1,0.5,-0.2,0.4,0.4,-0.8,-1.7,-2.0,-2.7,-3.1,-3.5
2017-08-29,-0.9,0.3,-1.2,0.5,0.5,-0.8,-2.0,-2.2,-2.9,-3.4,-3.8
2017-08-30,-0.9,0.5,-0.9,0.9,0.9,-1.2,-2.5,-2.9,-3.4,-4.0,-4.4
2017-08-31,-1.4,0.4,-1.4,1.9,1.9,-2.2,-3.7,-4.2,-4.8,-5.4,-5.8
2017-09-01,0.8,1.3,-0.3,-1.0,-1.0,-0.8,-2.2,-2.9,-3.5,-4.1,-4.7
2017-09-05,-0.5,0.7,-0.7,-0.2,-0.2,-0.2,-1.5,-2.5,-3.1,-3.8,-4.3
2017-09-06,0.2,0.7,-0.2,0.1,0.1,0.0,-1.2,-2.4,-2.9,-3.6,-4.2

2017-08-23: here's why clovis stock is up almost 60% so far in 2017  $clvs $pfe $bmy|rt AT_USER upstart blade nabs bristol-myers squibb research executive as new r&amp;d lead  $bmy #biotech #nash AT_USER|rt AT_US
2017-08-24: price returns vs expected daily move $immu $vrx $mrk $agn $bmy $gild $jnj $pfe $axon $teva $alny $cvs¡­ |rt AT_USER players: $mrk $sny $adro $nwbo $gsk $csl $azn with on lookers $bmy $exel $fgen $agio
2017-08-25: price returns vs expected daily move $adms $aveo $abbv $pfe $bmy $thc $cvs $jnj $celg $gild $teva $vrx¡­ |investors sell bristol-myers squibb company $bmy on strength $bmy |investors sell bristol-myer
2017-08-26: $bmy showing  the best technicals its sector  #nifty50 #mayweathermcgregor|investor ab has lowered its bristol myers squibb co $bmy stake by $1.10 million as stock value declined ...|bristol-myers squ
2017-08-27: rt AT_USER great entrepreneurs have the same ethos: be kind, generous, and stay positive.  $teva $bmy #friday¡­|icymi: here are the breakout stocks i'm watching this week:   #trading $spy $study $shop
2017-08-28: icymi: here are the breakout stocks i'm watching this week:   #trading $spy $study $shop¡­ |$bmy &amp;daiichi sankyo announce collaboration to evaluate opdivo &amp; ds-8201 in her2-expressing breast &
2017-08-29: pfizer presents encouraging eliquis results in nvaf patients $pfe also $bmy $jnj $ptla |celgene $celg ebitda multiple of 24.8x doesn't look attractive vs peers: $bmy $abbv $mrk $shpg $amgn¡­ |$bmy aft
2017-08-30: $halo (hyaluronidase) with cancer drugs, is like lemon (citric acid) with water/tea. increases absorption of liquids. $mrk $lly $bmy $nvs|see which one we favor and our email alert stats $orcl $cop $n
2017-08-31: what about a bristol-myers squibb takeover by pfizer?  $bmy $pfe|$spy $xlv $gild $pfe $bmy decreased promotion could further undermine its #insurance markets, which had been struggling $hum $aet $unh|
2017-09-01: rt AT_USER unusual call buying: $nrg 7x average volume, $sqqq 6x, $gild 5x, $gdxj 4x, $jci 4x, $lyb 4x, $bmy 4x, $thc 4x|s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $
2017-09-02: rt AT_USER what does it take to get hired by johnson &amp; johnson $jnj and bristol-myers squibb $bmy?  |opus point partners management boosted bristol myers squibb co $bmy stake by $2.61 million as s
2017-09-03: $mnk granted orphan designation by the fda for cosyntropin for the treatment of duchenne muscular dystrophy.. $ibb $xbi $gsk $nvs $bmy $pfe|bristol myers squibb co $bmy share price declined while fact
2017-09-04: mallinckrodt plc $mnk stake raised by california public employees retirement system $xbi $ibb $spy $bmy|$bmy "bmy potential" on the motley fool message boards: |bristol-myers squibb company $bmy share
2017-09-05: $bmy director dealings: bloomsbury publishing non-executive b¡­ |$oncs ah price up 6% and climbing. new hire happens to have been in charge of m&amp;a's. lol if you can't read between the lines $bmy $
2017-09-06: rt AT_USER $bmy says opdivo multiple myeloma trials are on hold. no surprise given keytruda hold and subsequent fda news. |rt AT_USER following recent $mrk pembro news fda has placed partial clinical 
Answer:
Contemplate the data and tweets to guess whether the closing price of $bmy will surge or decline at 2017-09-07. Please declare either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-08-23,-0.4,0.5,-0.8,0.3,0.3,-1.4,-1.2,-1.6,-2.2,-2.5,-3.0
2017-08-24,-0.3,0.3,-0.6,0.5,0.5,-1.4,-1.5,-1.8,-2.4,-2.8,-3.3
2017-08-25,-0.1,0.5,-0.3,0.3,0.3,-1.1,-1.5,-1.9,-2.5,-3.0,-3.4
2017-08-28,0.1,0.5,-0.2,0.4,0.4,-0.8,-1.7,-2.0,-2.7,-3.1,-3.5
2017-08-29,-0.9,0.3,-1.2,0.5,0.5,-0.8,-2.0,-2.2,-2.9,-3.4,-3.8
2017-08-30,-0.9,0.5,-0.9,0.9,0.9,-1.2,-2.5,-2.9,-3.4,-4.0,-4.4
2017-08-31,-1.4,0.4,-1.4,1.9,1.9,-2.2,-3.7,-4.2,-4.8,-5.4,-5.8
2017-09-01,0.8,1.3,-0.3,-1.0,-1.0,-0.8,-2.2,-2.9,-3.5,-4.1,-4.7
2017-09-05,-0.5,0.7,-0.7,-0.2,-0.2,-0.2,-1.5,-2.5,-3.1,-3.8,-4.3
2017-09-06,0.2,0.7,-0.2,0.1,0.1,0.0,-1.2,-2.4,-2.9,-3.6,-4.2

2017-08-23: here's why clovis stock is up almost 60% so far in 2017  $clvs $pfe $bmy|rt AT_USER upstart blade nabs bristol-myers squibb research executive as new r&amp;d lead  $bmy #biotech #nash AT_USER|rt AT_US
2017-08-24: price returns vs expected daily move $immu $vrx $mrk $agn $bmy $gild $jnj $pfe $axon $teva $alny $cvs¡­ |rt AT_USER players: $mrk $sny $adro $nwbo $gsk $csl $azn with on lookers $bmy $exel $fgen $agio
2017-08-25: price returns vs expected daily move $adms $aveo $abbv $pfe $bmy $thc $cvs $jnj $celg $gild $teva $vrx¡­ |investors sell bristol-myers squibb company $bmy on strength $bmy |investors sell bristol-myer
2017-08-26: $bmy showing  the best technicals its sector  #nifty50 #mayweathermcgregor|investor ab has lowered its bristol myers squibb co $bmy stake by $1.10 million as stock value declined ...|bristol-myers squ
2017-08-27: rt AT_USER great entrepreneurs have the same ethos: be kind, generous, and stay positive.  $teva $bmy #friday¡­|icymi: here are the breakout stocks i'm watching this week:   #trading $spy $study $shop
2017-08-28: icymi: here are the breakout stocks i'm watching this week:   #trading $spy $study $shop¡­ |$bmy &amp;daiichi sankyo announce collaboration to evaluate opdivo &amp; ds-8201 in her2-expressing breast &
2017-08-29: pfizer presents encouraging eliquis results in nvaf patients $pfe also $bmy $jnj $ptla |celgene $celg ebitda multiple of 24.8x doesn't look attractive vs peers: $bmy $abbv $mrk $shpg $amgn¡­ |$bmy aft
2017-08-30: $halo (hyaluronidase) with cancer drugs, is like lemon (citric acid) with water/tea. increases absorption of liquids. $mrk $lly $bmy $nvs|see which one we favor and our email alert stats $orcl $cop $n
2017-08-31: what about a bristol-myers squibb takeover by pfizer?  $bmy $pfe|$spy $xlv $gild $pfe $bmy decreased promotion could further undermine its #insurance markets, which had been struggling $hum $aet $unh|
2017-09-01: rt AT_USER unusual call buying: $nrg 7x average volume, $sqqq 6x, $gild 5x, $gdxj 4x, $jci 4x, $lyb 4x, $bmy 4x, $thc 4x|s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $
2017-09-02: rt AT_USER what does it take to get hired by johnson &amp; johnson $jnj and bristol-myers squibb $bmy?  |opus point partners management boosted bristol myers squibb co $bmy stake by $2.61 million as s
2017-09-03: $mnk granted orphan designation by the fda for cosyntropin for the treatment of duchenne muscular dystrophy.. $ibb $xbi $gsk $nvs $bmy $pfe|bristol myers squibb co $bmy share price declined while fact
2017-09-04: mallinckrodt plc $mnk stake raised by california public employees retirement system $xbi $ibb $spy $bmy|$bmy "bmy potential" on the motley fool message boards: |bristol-myers squibb company $bmy share
2017-09-05: $bmy director dealings: bloomsbury publishing non-executive b¡­ |$oncs ah price up 6% and climbing. new hire happens to have been in charge of m&amp;a's. lol if you can't read between the lines $bmy $
2017-09-06: rt AT_USER $bmy says opdivo multiple myeloma trials are on hold. no surprise given keytruda hold and subsequent fda news. |rt AT_USER following recent $mrk pembro news fda has placed partial clinical 
Answer:+Rise